Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to $2.6 million.

  • Ptc Therapeutics' Other Non-Current Liabilities fell 8827.73% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 8827.73%. This contributed to the annual value of $21.4 million for FY2024, which is 4097.52% down from last year.
  • Per Ptc Therapeutics' latest filing, its Other Non-Current Liabilities stood at $2.6 million for Q3 2025, which was down 8827.73% from $7.8 million recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Other Non-Current Liabilities registered a high of $252.0 million during Q3 2021, and its lowest value of $2.6 million during Q3 2025.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $39.0 million (2023), whereas its average is $110.5 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first soared by 764.63% in 2021, then crashed by 8827.73% in 2025.
  • Ptc Therapeutics' Other Non-Current Liabilities (Quarter) stood at $239.9 million in 2021, then crashed by 31.64% to $164.0 million in 2022, then crashed by 77.87% to $36.3 million in 2023, then tumbled by 40.98% to $21.4 million in 2024, then tumbled by 87.96% to $2.6 million in 2025.
  • Its Other Non-Current Liabilities was $2.6 million in Q3 2025, compared to $7.8 million in Q2 2025 and $22.4 million in Q1 2025.